{"id":"https://openalex.org/W2355600692","doi":null,"title":"Effect of nattokinase on coagulation system in normal rats","display_name":"Effect of nattokinase on coagulation system in normal rats","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2355600692","mag":"2355600692"},"language":"en","primary_location":{"id":"mag:2355600692","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=LNXG201209027","pdf_url":null,"source":{"id":"https://openalex.org/S2764739207","display_name":"Zhonghua laonian xin-nao-xueguanbing zazhi","issn_l":"1009-0126","issn":["1009-0126"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4360969430","host_organization_name":"People\u2019s Liberation Army","host_organization_lineage":["https://openalex.org/P4360969430"],"host_organization_lineage_names":["People\u2019s Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhonghua laonian xin-nao-xueguanbing zazhi","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2355600692"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shi Yan-mao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shi Yan-mao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nattokinase","display_name":"nattokinase","score":1.0},{"id":"https://openalex.org/keywords/anticoagulant-activity","display_name":"anticoagulant activity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/prothrombin-time","display_name":"prothrombin time","score":0.984000027179718},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":1.0},{"id":"https://openalex.org/keywords/thrombin-time","display_name":"thrombin time","score":0.9990000128746033},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.8500000238418579},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.8619999885559082},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.718999981880188},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.8759999871253967},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.8632349967956543},{"id":"https://openalex.org/C2780077467","wikidata":"https://www.wikidata.org/wiki/Q2520736","display_name":"Thrombin time","level":4,"score":0.6902614831924438},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.6883959770202637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6475825309753418},{"id":"https://openalex.org/C2780434524","wikidata":"https://www.wikidata.org/wiki/Q1144385","display_name":"Prothrombin time","level":2,"score":0.6460891366004944},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.6269620656967163},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4866391122341156},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4227154850959778},{"id":"https://openalex.org/C2778568395","wikidata":"https://www.wikidata.org/wiki/Q11323875","display_name":"Nattokinase","level":3,"score":0.41772374510765076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4128956198692322},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3243290185928345},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15430304408073425},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12192884087562561},{"id":"https://openalex.org/C100544194","wikidata":"https://www.wikidata.org/wiki/Q41760","display_name":"Fermentation","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2355600692","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=LNXG201209027","pdf_url":null,"source":{"id":"https://openalex.org/S2764739207","display_name":"Zhonghua laonian xin-nao-xueguanbing zazhi","issn_l":"1009-0126","issn":["1009-0126"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4360969430","host_organization_name":"People\u2019s Liberation Army","host_organization_lineage":["https://openalex.org/P4360969430"],"host_organization_lineage_names":["People\u2019s Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhonghua laonian xin-nao-xueguanbing zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2394226061","https://openalex.org/W2356574925","https://openalex.org/W2404423380","https://openalex.org/W2377158220","https://openalex.org/W2380468114","https://openalex.org/W1965307763","https://openalex.org/W3208211942","https://openalex.org/W2352018269","https://openalex.org/W2362874596","https://openalex.org/W2392948544"],"abstract_inverted_index":{"Objective":[0],"To":[1],"study":[2],"the":[3,82],"anticoagulant":[4,150],"effect":[5],"of":[6],"intrmuscular":[7],"injection":[8,53,99,131],"with":[9],"dry":[10],"nattokinase":[11],"(NK)":[12],"powder(NK-l)":[13],"and":[14,25,74,88,127,142],"solid":[15],"NK":[16],"powder(NK-2)":[17],"by":[18],"measuring":[19],"prothrombin":[20],"time(PT),activated":[21],"partial":[22],"thromboplastin":[23],"time(APTT)":[24],"thrombin":[26],"time(TT)":[27],"in":[28,71,78,93,115,122,134,152,156],"normal":[29,157],"rats.Methods":[30],"Eighty":[31],"SD":[32],"rats":[33],"were":[34,76,84,90],"randomly":[35],"divided":[36],"into":[37],"control":[38,40,43,46,105,108,112,116,124,135],"group,heparin":[39,104],"group":[41,44,106,109,113,125,132],"1,heparin":[42,107],"2,aspirin":[45],"group,and":[47],"low,medium":[48,61,94],"amd":[49,62,95],"high":[50,63,96,128],"NK-1":[51,97,129,137],"dose":[52,65,98,102,130],"groups(1.6":[54],"-":[55],"25.9\u00d710~4":[56],"U/kg":[57,68,139,145],"\u00b7":[58,69,140,146],"d),and":[59],"oral":[60,103,143],"NK-2":[64,101],"groups(0.5~":[66],"7.5\u00d710~4":[67],"d),8":[70],"each":[72],"group.APTT,TT":[73],"PT":[75,87],"recorded":[77],"different":[79],"groups":[80],"after":[81],"drugs":[83],"used.Results":[85],"The":[86],"APTT":[89],"significantly":[91,120],"longer":[92,121],"groups,high":[100],"2,and":[110],"aspirin":[111],"than":[114,133],"group(PC0.05,PC0.01).The":[117],"TT":[118],"was":[119],"heparin":[123],"1":[126],"group(P0.01).Conclusion":[136],"injection(1.6-25.9\u00d710~4":[138],"d)":[141,147],"NK-2(0.5-7.5\u00d710~4":[144],"exert":[148],"their":[149],"effects":[151],"a":[153],"dose-dependent":[154],"manner":[155],"rats.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2355600692","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
